A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2004
12/23/2004	US20040256383 Apparatus and methods for single sheet forming using induction heating
12/23/2004	DE10325049A1 New peptide derivatives containing cell-adhesion molecule and phosphonate-containing anchor component, useful for treating disorders associated with implants, are inhibitors of integrins
12/23/2004	DE10103860B4 Transdermales therapeutisches System für die Verabreichung carboxylgruppenhaltiger, nichtsteroidaler Antiphlogistika, sowie Verfahren zu seiner Herstellung Transdermal therapeutic system for the administration of carboxyl-containing, non-steroidal anti-inflammatory agents, and to processes for its preparation
12/23/2004	CA2849228A1 Process for the manufacture of stable shaped particles consisting of estradiol and cholesterol
12/23/2004	CA2737127A1 Maytansinoid-antibody conjugate compositions
12/23/2004	CA2569585A1 Compositions for oral administration of campothecin and its analogs
12/23/2004	CA2563361A1 Cell permeable conjugates of peptides for inhibition of protein kinases
12/23/2004	CA2536357A1 Targeted delivery to legumain-expressing cells
12/23/2004	CA2531890A1 Peptides enhancing ceh activity or inhibiting acat activity for treating atherosclerosis
12/23/2004	CA2529972A1 Polymeric conjugates for tissue activated drug delivery
12/23/2004	CA2529496A1 Anti-cd74 immunoconjugates and methods
12/23/2004	CA2528869A1 Directing cells to target tissues or organs
12/23/2004	CA2528413A1 Radial spherical crystallization product, process for producing the same and dry powder preparation containing the crystallization product
12/23/2004	CA2528402A1 Sphingoid polyalkylamine conjugates for vaccination
12/23/2004	CA2528360A1 Anesthetic composition for topical administration comprising lidocaine, prilocaine and tetracaine
12/23/2004	CA2524639A1 Compositions and methods for reducing scar tissue formation
12/23/2004	CA2520148A1 Compositions and methods for treating coronavirus infection and sars
12/22/2004	EP1489126A1 Polymers for the delivery of bioactive agents and methods of their preparation
12/22/2004	EP1489125A1 Compound of hydrophilic polymer-polycarboxyl oligopeptide and medicines, medical composite comprising above compound and use of above compound in medicimes
12/22/2004	EP1489100A2 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
12/22/2004	EP1489099A2 Antibodies that bind the CD40CR receptor
12/22/2004	EP1488812A1 Liquid matrix undergoing phase transfer in vivo and liquid oral preparations
12/22/2004	EP1488810A1 Percutaneous absorption promoters and compositions for treating athlete's foot
12/22/2004	EP1488804A1 Immunoglobulin/hydrophilic peptide complexes
12/22/2004	EP1488801A1 Chemical igf-i composition for the treatment and prevention of neurodegenerative diseases
12/22/2004	EP1488800A1 Agent for the treatment of protozoal diseases
12/22/2004	EP1488790A1 Solid preparation containing single crystal form
12/22/2004	EP1488789A1 Eye drops containing tetrazole derivative
12/22/2004	EP1488787A1 Topical stabilized formulations containing ketoprofen
12/22/2004	EP1488786A1 Melt-extruded orally administrable opioid formulations
12/22/2004	EP1488784A1 Male contraceptive implant
12/22/2004	EP1487995A2 Protein carrier system for therapeutic oligonucleotides
12/22/2004	EP1487992A2 Central airway administration for systemic delivery of therapeutics
12/22/2004	EP1487879A2 Bispecific antibody point mutations for enhancing rate of clearance
12/22/2004	EP1487877A2 Compositions and methods for the diagnosis and treatment of tumor
12/22/2004	EP1487875A2 Antibody that binds to a dimer of a prion protein for the treatment of tse infection
12/22/2004	EP1487855A2 Method of using modified oligonucleotides for hepatic delivery
12/22/2004	EP1487832A1 Micronized crystalline tiotropium bromide
12/22/2004	EP1487791A1 A novel antifungal molecule 2-(3,4-dimethyl-2,5-dihydro-1h-pyrrol-2-yl)- methylethyl pentanoate
12/22/2004	EP1487540A2 Storage stable eplerenone formulation
12/22/2004	EP1487539A1 Lower esophagus tissue modifier
12/22/2004	EP1487514A1 Deposition method for endoprostheses provided for constantly administering medicaments
12/22/2004	EP1487498A1 Topical composition comprising a cyclofructan, a carrier and a drug
12/22/2004	EP1487496A1 Test system for evaluating the compatibility of biologically active substances with copolymers
12/22/2004	EP1487493A2 Conjugates of therapeutic or cytotoxic agents and biologically active peptides
12/22/2004	EP1487492A1 The prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents
12/22/2004	EP1487489A2 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN avb3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE
12/22/2004	EP1487484A2 Use of mixtures of lipopeptides for vaccine production
12/22/2004	EP1487479A2 Mutant glycoproteins
12/22/2004	EP1487469A1 Co-beadlet of dha and rosemary and methods of use
12/22/2004	EP1487462A2 Preparations for topical skin use and treatment
12/22/2004	EP1487459A1 Peptide analogues and uses thereof
12/22/2004	EP1487439A1 Solubilization of weak bases
12/22/2004	EP1487432A2 Suramin and derivatives thereof as topical microbicide and contraceptive
12/22/2004	EP1487430A1 Methods for treating diseases related to intraocular pressure
12/22/2004	EP1487426A2 Methods of inducing terminal differentiation
12/22/2004	EP1487423A1 Novel formulation
12/22/2004	EP1487421A2 Pharmaceutical formulation for the active ingredient budesonide
12/22/2004	EP1487419A2 Fast dissolving dosage forms having reduced friability
12/22/2004	EP1487417A2 Dry powder medicament formulations
12/22/2004	EP1487416A2 Drug microparticles
12/22/2004	EP1487413A1 An inhalation system for prevention and treatment of intracellular infections
12/22/2004	EP1487411A2 Inhalable sustained therapeutic formulations
12/22/2004	EP1487410A2 Preparation of sterile stabilized nanodispersions
12/22/2004	EP1487409A2 Highly aqueous liquid carrier formulations
12/22/2004	EP1487408A1 Topical composition based on ion-exchange resins, in particular for treating erythemas
12/22/2004	EP1487406A1 Heat-reversible composition treating hyposalia and asialia
12/22/2004	EP1487345A1 Device and method for quantifying bodies by means of ultrasound
12/22/2004	EP1487272A1 Choline-silicic acid complex with osmolytes and divalent trace elements
12/22/2004	EP1427380A4 Fluid-to-powder compositions
12/22/2004	EP1401567B1 Unimolecular polymeric micelles with an ionizable inner core
12/22/2004	EP1355635B1 New film coating
12/22/2004	EP1206249A4 Hydrodynamically balancing oral drug delivery system
12/22/2004	EP1161480B1 Biodegradable and thermosensitive polyphosphazenes and their preparation method
12/22/2004	EP1082135B1 Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants
12/22/2004	EP1042405B1 Gelatine compositions
12/22/2004	EP1003476B1 Prolonged release active agent dosage form adapted for gastric retention
12/22/2004	EP0956026B1 Pharmaceutical preparations comprised of salts of hyaluronic acid with local anaesthetics
12/22/2004	EP0929536B1 Piperazine based cytofectins
12/22/2004	EP0918535B1 Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid
12/22/2004	EP0906110B1 Dna vaccine formulations
12/22/2004	EP0896534B1 Injection formulations of avermectins and milbemycins based on castor oil
12/22/2004	EP0825877B1 Composition for prevention of posterior capsule opacification
12/22/2004	EP0746294B1 Absorption enhancers for topical pharmaceutical formulations
12/22/2004	CN1556828A Hydrophili polymer derirative having Y shaped branch, its preparation method, combined object with medicine molecule and medical compositon containing combined object
12/22/2004	CN1556827A Target hydrophili polymer and its combined object with interferon and medicinal composition conteining said combined object
12/22/2004	CN1556712A Pharmaceutical compositions containing DDS compounds
12/22/2004	CN1556704A Local use medicinal composition
12/22/2004	CN1556697A Controlled drug delivery systems providing variable release rates
12/22/2004	CN1556696A Zero order controlled drug delivery system
12/22/2004	CN1556695A 协同填料组合物 Synergistic filler composition
12/22/2004	CN1556694A Method for obtaining aqueous formulations of oxidation-sensitive active principles
12/22/2004	CN1556130A Preparation method of bioactive polylactic acid its product and application
12/22/2004	CN1555843A Ginkgoleaf oral cavity disintegrating tablet and its preparation method
12/22/2004	CN1555784A Calcium alginate/polyhistidine medicine controlled release micro capsule and its manufacturing method
12/22/2004	CN1181092C Conjugates useful in treatment of prostate cancer
12/22/2004	CN1180846C Gel-like pharmaceutical composition for subcutaneous administration comprising bisphosphonic acids or their salts
12/22/2004	CN1180841C Method to enhance healing of sternum after sternotomy
12/22/2004	CN1180840C Cyclosphorin-containing soft capsule preparation
12/22/2004	CN1180839C Powdery preparation containing polymeric medicine for mucosal administration

1 ... 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 ... 1712